CLINICAL_TRIALS
trial_result
· 2016-03-16
Clinical Trial Update: Study of Mantle Cell Lymphoma Treatment by RiBVD [Phase 2]
Summary
A Phase 2 clinical trial evaluating the RiBVD regimen for mantle cell lymphoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: French Innovative Leukemia Organisation | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: COMPLETED